Department of Radiology
Found 22 results
Filters: Author is Zanzonico, Pat B  [Clear All Filters]
2023
Chung SK, Vargas DBurnes, Chandler CS, Katugampola S, Veach DR, McDevitt MR, Seo SH, Vaughn BA, Rinne SS, Punzalan B et al..  2023.  Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.. J Nucl Med. 64(9):1439-1445.
Fung EK, Zanzonico PB.  2023.  Monitoring the biodistribution of radiolabeled therapeutics in mice.. Methods Cell Biol. 180:93-111.
2022
Chandler CS, Bell MM, Chung SK, Veach DR, Fung EK, Punzalan B, Vargas DBurnes, Patel M, Xu H, Guo H-F et al..  2022.  Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis.. Mol Cancer Ther. 21(1):125-137.
2021
Cheal SM, Patel M, Yang G, Veach DR, Xu H, Guo H-F, Zanzonico PB, Axworthy DB, Cheung N-KV, Ouerfelli O et al..  2021.  Correction to An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy.. Bioconjug Chem. 32(2):394.
Yerrabelli RS, He P, Fung EK, Kramer K, Zanzonico PB, Humm JL, Guo H, Pandit-Taskar N, Larson SM, Cheung N-KV.  2021.  IntraOmmaya compartmental radioimmunotherapy using I-omburtamab-pharmacokinetic modeling to optimize therapeutic index.. Eur J Nucl Med Mol Imaging. 48(4):1166-1177.
Santich BH, Cheal SM, Ahmed M, McDevitt MR, Ouerfelli O, Yang G, Veach DR, Fung EK, Patel M, Vargas DBurnes et al..  2021.  A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy.. Clin Cancer Res. 27(2):532-541.
2020
Cheal SM, Patel M, Yang G, Veach D, Xu H, Guo H-F, Zanzonico PB, Axworthy DB, Cheung N-KV, Ouerfelli O et al..  2020.  An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy.. Bioconjug Chem. 31(3):501-506.
2019
Pandit-Taskar N, Zanzonico PB, Kramer K, Grkovski M, Fung EK, Shi W, Zhang Z, Lyashchenko SK, Fung AM, Pentlow KS et al..  2019.  Biodistribution and Dosimetry of Intraventricularly Administered I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors.. J Nucl Med. 60(12):1794-1801.
O'Donoghue JA, Danila DC, Pandit-Taskar N, Beylergil V, Cheal SM, Fleming SE, Fox JJ, Ruan S, Zanzonico PB, Ragupathi G et al..  2019.  Pharmacokinetics and Biodistribution of a [Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients.. Mol Pharm. 16(7):3083-3090.
2018
Cheal SM, Ruan S, Veach DR, Longo VA, Punzalan BJ, Wu J, Fung EK, Kelly MP, Kirshner JR, Giurleo JT et al..  2018.  ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor Xenografts.. Mol Pharm. 15(6):2133-2141.
Cheal SM, Xu H, Guo H-F, Patel M, Punzalan B, Fung EK, Lee S-G, Bell M, Singh M, Jungbluth AA et al..  2018.  Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma.. Theranostics. 8(18):5106-5125.
2017
Cheal SM, Fung EK, Patel M, Xu H, Guo H-F, Zanzonico PB, Monette S, K Wittrup D, Cheung N-KV, Larson SM.  2017.  Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.. J Nucl Med. 58(11):1735-1742.
Schwartz J, Grkovski M, Rimner A, Schöder H, Zanzonico PB, Carlin SD, Staton KD, Humm JL, Nehmeh SA.  2017.  Pharmacokinetic Analysis of Dynamic F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.. J Nucl Med. 58(6):911-919.
2016
Grkovski M, Schwartz J, Gönen M, Schöder H, Lee NY, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA.  2016.  Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times.. J Nucl Med. 57(3):334-41.
Grkovski M, Schwartz J, Rimner A, Schöder H, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA.  2016.  Reproducibility of F-fluoromisonidazole intratumour distribution in non-small cell lung cancer.. EJNMMI Res. 6(1):79.
Fung EK, Cheal SM, Fareedy SB, Punzalan B, Beylergil V, Amir J, Chalasani S, Weber WA, Spratt DE, Veach DR et al..  2016.  Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling.. EJNMMI Res. 6(1):7.
Cheal SM, Xu H, Guo H-F, Lee S-G, Punzalan B, Chalasani S, Fung EK, Jungbluth A, Zanzonico PB, Carrasquillo JA et al..  2016.  Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.. Eur J Nucl Med Mol Imaging. 43(5):925-937.
2014
Cheal SM, Xu H, Guo H-F, Zanzonico PB, Larson SM, Cheung N-K.  2014.  Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex.. Mol Cancer Ther. 13(7):1803-12.
2013
Kleiman DA, Buitrago D, Crowley MJ, Beninato T, Veach AJ, Zanzonico PB, Jin M, Fahey TJ, Zarnegar R.  2013.  Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing.. J Surg Res. 182(1):85-93.
2009
Wang W, Georgi J-C, Nehmeh SA, Narayanan M, Paulus T, Bal M, O'Donoghue J, Zanzonico PB, C Schmidtlein R, Lee NY et al..  2009.  Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging.. Phys Med Biol. 54(10):3083-99.
2008
Nehmeh SA, Lee NY, Schröder H, Squire O, Zanzonico PB, Erdi YE, Greco C, Mageras G, Pham HS, Larson SM et al..  2008.  Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.. Int J Radiat Oncol Biol Phys. 70(1):235-42.
2006
Zanzonico PB, Nehmeh SA.  2006.  Introduction to clinical and laboratory (small-animal) image registration and fusion.. Conf Proc IEEE Eng Med Biol Soc. 2006:1580-3.